New Advance Treatments in Parkinson’s and Tremors

'Parkinson's disease (PD) is the second most common neurodegenerative disease, ranking lower only than Alzheimer Parkinsons disease, and affects more than 10 million people worldwide. The average prevalence of PD in the Han population in China is ~3.9‰ of those ≥50 years of age. It is estimated that the number of Chinese patients with PD will increase to 4.94 million by 2030, accounting for half of PD patients worldwide.'- Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study.

Join us for a valuable update on New Advance Treatments by a local expert.

Date: Thursday 18th April 2024

Venue: Novotel Glen Waverley

Time 6.30pm for 7pm start

Speaker: Dr Mina Ghaly (General Neurologist & Movement disorder specialist)

Proudly sponsored by Metronic